tariquidar has been researched along with 1-[[4-[(4-fluorophenyl)methyl]-5-thieno[3,2-b]pyrrolyl]-oxomethyl]-N-(2-furanylmethyl)-4-piperidinecarboxamide in 1 studies
Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (1-[[4-[(4-fluorophenyl)methyl]-5-thieno[3,2-b]pyrrolyl]-oxomethyl]-N-(2-furanylmethyl)-4-piperidinecarboxamide) | Trials (1-[[4-[(4-fluorophenyl)methyl]-5-thieno[3,2-b]pyrrolyl]-oxomethyl]-N-(2-furanylmethyl)-4-piperidinecarboxamide) | Recent Studies (post-2010) (1-[[4-[(4-fluorophenyl)methyl]-5-thieno[3,2-b]pyrrolyl]-oxomethyl]-N-(2-furanylmethyl)-4-piperidinecarboxamide) |
---|---|---|---|---|---|
210 | 16 | 138 | 6 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barraza, SJ; Blakely, PK; Dobry, CJ; Irani, DN; Keep, RF; Larsen, SD; Miller, DJ; Sindac, JA; Xiang, J | 1 |
1 other study(ies) available for tariquidar and 1-[[4-[(4-fluorophenyl)methyl]-5-thieno[3,2-b]pyrrolyl]-oxomethyl]-N-(2-furanylmethyl)-4-piperidinecarboxamide
Article | Year |
---|---|
Optimization of novel indole-2-carboxamide inhibitors of neurotropic alphavirus replication.
Topics: Animals; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Drug Design; Encephalitis Virus, Western Equine; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Mice; Molecular Weight; Solubility; Structure-Activity Relationship; Virus Replication | 2013 |